First Amendment to Exclusive Patent License Agreement A217008.04Exclusive Patent License Agreement • June 5th, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 5th, 2020 Company IndustryThis First Amendment (“First Amendment”) to the Exclusive Patent License Agreement MGH # A217008, (the “Agreement”), dated July 23, 2013 is made as of August 15, 2016 (“First Amendment Effective Date) by and between The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit Massachusetts corporation, with a principal place of business at 55 Fruit Street, Boston, Massachusetts 02114 and ArcherDx, Inc., a Delaware Corporation, having a principal place of business at 2477 55th St. # 202 Boulder, Colorado 80301.
First Amendment to Exclusive Patent License Agreement A217008.04Exclusive Patent License Agreement • April 21st, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledApril 21st, 2020 Company IndustryThis First Amendment (“First Amendment”) to the Exclusive Patent License Agreement MGH # A217008, (the “Agreement”), dated July 23, 2013 is made as of August 15, 2016 (“First Amendment Effective Date) by and between The General Hospital Corporation, d/b/a Massachusetts General Hospital, a not-for-profit Massachusetts corporation, with a principal place of business at 55 Fruit Street, Boston, Massachusetts 02114 and ArcherDx, Inc., a Delaware Corporation, having a principal place of business at 2477 55th St. # 202 Boulder, Colorado 80301.